Exchange traded funds (ETFs) continue to grow in popularity with investors and it isn’t hard to see why.

Never has it been so easy for investors to gain access to groups of shares from all corners of the world.

But which ones should you consider if you want to invest globally? Two that could help you achieve your goals are listed below. Here’s what you need to know about these ETFs:

iShares S&P 500 ETF (ASX: IVV)

The first ETF that could be a great option for investors wanting to invest globally is the iShares S&P 500 ETF.

This popular ETF aims to provide investors with the performance of the famous S&P 500 Index, before fees and expenses. This index is home to 500 of the largest listed companies on Wall Street.

BlackRock, which operates the fund, highlights that the ETF allows Australian investors to diversify internationally and seek long-term growth opportunities for a portfolio.

Among its largest holdings are global giants such as Amazon, Apple, Coca-Cola Company, Johnson & Johnson, Mastercard, McDonalds, Microsoft, Nike, Tesla, and Visa.

Vanguard MSCI Index International Shares ETF (ASX: VGS)

Another ETF to consider if you want to invest globally is the Vanguard MSCI Index International Shares ETF.

This ETF gives investors exposure to approximately 1,500 of the world’s largest listed companies from major developed countries.

Vanguard, which operates the fund, notes that the ETF offers low-cost access to a broadly diversified range of securities that allow investors to benefit from the long-term growth potential of the global economy.

The fund manager believes this this makes it a decent option for buy and hold investors that are seeking long-term capital growth, some income, and international diversification.

Among the global giants you’ll be owning a slice of with this fund are Apple, HSBC, LVMH Moet Hennessy Louis Vuitton, Nestle, Procter & Gamble, Roche, Royal Bank of Canada, Shell, and Visa.

The post Want to invest globally? Here are 2 international ETFs for ASX investors appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• This ASX ETF was my first investment, and I’ll be holding it for the long term
• How much is too little to start investing in ASX shares?
• 3 quality ETFs for ASX investors to buy now
• What does Warren Buffett think about investing in ETFs?
• Could right now be the perfect time to buy the Vanguard Index International Shares ETF?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Vanguard MSCI Index International Shares ETF. The Motley Fool Australia has recommended Vanguard MSCI Index International Shares ETF and iShares Trust – iShares Core S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/WZbd9ci

If you’re a fan of growth shares like I am, then you’ll be pleased to hear that a number have recently been rated as buys by leading brokers.

Two such ASX shares are listed below. Here’s what analysts at Goldman Sachs are saying about them:

IDP Education Ltd (ASX: IEL)

The first ASX growth share that could be a good option for investors is IDP Education.

It is a provider of international student placement services and English language testing services across the world.

IDP is also the co-owner of the IELTS language test. This is preeminent English language test, which millions of students take each year.

IDP has been growing at a rapid rate since the worst of the pandemic passed and appears well-placed to continue this positive form in the coming years. This is thanks to structural growth and recent acquisitions.

Goldman Sachs is very bullish and is forecasting a 68% three-year earnings per share compound annual growth rate between FY 2021 and FY 2024.

The broker currently has a buy rating and $36.00 price target on its shares.

Temple & Webster Group Ltd (ASX: TPW)

Another ASX growth share that could be a good option for investors according to Goldman Sachs is Temple & Webster.

It is Australia’s leading pure-play online retailer of furniture and homewares.

Goldman Sachs believes Temple & Webster is well-placed for long term growth. This is thanks to its leadership position in a retail category that is still only in the early stages of shifting online.

The broker also highlights that the category favours scale players, requires a specialised approach to e-commerce, and has higher barriers to entry. Temple & Webster ticks these boxes.

Goldman has a buy rating and $7.55 price target on the company’s shares.

The post 2 ASX growth shares that this leading broker rates as buys appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Top brokers name 3 ASX shares to buy next week
• 2 ASX 200 shares rated as buys by leading brokers
• Top brokers name 3 ASX shares to buy today
• Looking to buy ASX shares? Expert reveals ‘one metric to assess the quality of a business’
• Why Brickworks, IDP Education, IGO, and New Hope shares are racing higher

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Idp Education Pty Ltd and Temple & Webster Group Ltd. The Motley Fool Australia has recommended Temple & Webster Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/fjuHzro

Last week saw a number of broker notes hitting the wires once again. Three buy ratings that investors might want to be aware of are summarised below.

Here’s why brokers think investors ought to buy them next week:

Aristocrat Leisure Limited (ASX: ALL)

According to a note out of Citi, its analysts have retained their buy rating with a slightly trimmed price target of $40.20. Citi notes that US casino industry revenues are sustaining at much higher levels than history but higher supply-chain costs are impacting margins. This has led to the broker trimming its earnings estimates slightly. Nevertheless, Citi expects this to be temporary and remains positive on the future. Particularly given that Aristocrat holds five of the top 10 premium/leased titles by installed base and has newer machines growing rapidly in popularity. The Aristocrat share price ended the week at $32.88.

Coles Group Ltd (ASX: COL)

A note out of Morgans reveals that its analysts have retained their add rating and $20.00 price target on this supermarket giant’s shares. This follows news that the company has agreed to sell its Coles Express business for $300 million. Morgans expects this to allows Coles to focus on its core business and free up balance sheet capacity. The Coles share price was fetching $16.34 at the end of the week.

IDP Education Ltd (ASX: IEL)

Analysts at Goldman Sachs have retained their buy rating and $36.00 price target on this language testing and student placement company’s shares. Goldman notes that IDP has announced an agreement to acquire Intake Education for up to $83 million. The broker is positive on the deal and believes it could allow IDP to grow its market share of UK student placements. It also sees cross-sell opportunities. The IDP share price ended the week at $26.51.

The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 2 ASX growth shares that Morgans rates as buys
• Brokers name 3 ASX shares to buy today
• Goldman Sachs gives its verdict on the Coles share price
• 2 ASX 200 shares rated as buys by leading brokers
• Here are 2 ASX 200 blue chip shares that experts rate as buys

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Idp Education Pty Ltd. The Motley Fool Australia has positions in and has recommended COLESGROUP DEF SET. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/JnLtGYU

Looking for some blue chip additions to your portfolio? Listed below are a couple of ASX 200 blue chip shares that have been given buy ratings by analysts

Here’s why its analysts rate them highly right now:

ResMed Inc. (ASX: RMD)

The first blue chip ASX 200 share that has been named as a buy is ResMed.

It is a medical device company with a focus on sleep treatment and respiratory products. These products treat disorders such as sleep apnoea and chronic obstructive pulmonary disease (COPD).

These certainly are great markets to be in.  For example, in respect to the former, the company estimates that upwards of 1 in 5 people are believed to suffer from sleep apnoea.

And with the vast majority currently undiagnosed, this provides a significant long term growth runway. Particularly given its industry-leading products, high level of investment in research and development each year, and wide distribution network.

Goldman Sachs is bullish on ResMed. It currently has a buy rating and $36.80 price target on its shares. This compares to the latest ResMed share price of $32.04.

Treasury Wine Estates Ltd (ASX: TWE)

Another blue chip ASX 200 share that is highly rated is Treasury Wine. It the global wine giant behind a range of popular brands including Penfolds.

Treasury Wine certainly has been through a lot in recent years but has come out of it looking arguably stronger.

In fact, the team at Morgans believe “the foundations are now in place for TWE to deliver strong earnings growth” in the coming years.

In light of this, Morgans has named Treasury Wine as a “key pick” and put an add rating and $13.93 price target on its shares. This compares to the current Treasury Wine share price of $12.55.

The post Experts names the blue chip ASX 200 shares to buy appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Experts name 2 outstanding ASX 200 shares to buy right now
• Looking to buy ASX shares? Expert reveals ‘one metric to assess the quality of a business’
• I regret not buying 2 ASX shares that became 10-baggers: fundie
• Why experts say these ASX growth shares are buys
• Analysts name 2 excellent blue chip ASX 200 shares to buy now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Treasury Wine Estates Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/09rqXtL